Prospective studies of cothymia (mixed anxiety-depression): how do they inform clinical practice?

被引:19
作者
Tyrer, Peter [1 ]
Seivewright, Helen [1 ]
Simmonds, Shaeda [1 ]
Johnson, Tony [2 ]
机构
[1] Paterson Ctr, London W2 1PD, England
[2] MRC, Biostat Unit, Cambridge CB2 2BW, England
关键词
Anxiety; depression; comorbidity; classification; outcome;
D O I
10.1007/BF03035128
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
We suggest that the diagnosis of mixed anxiety depression at syndromal level (i.e. both anxiety and depressive diagnoses present in the same person and given equal status) is valuable clinically and should be introduced into the formal classification of neurotic and mood disorders. Evidence is given from a systematic review that cothymia has a significantly worse outcome than either an anxiety or a depressive diagnosis alone (p < 0.0001). Long-term follow-up data in a 12-year outcome study of neurotic disorder reinforce this finding both with regard to social functioning and the clinical course of anxiety and depressive disorders; these were significantly worse (P < 0.001 and P < 0.02 respectively) in those with cothymia compared with single anxiety disorders. These outcome differences are much greater than those between anxiety and depressive disorders alone.
引用
收藏
页码:53 / 56
页数:4
相关论文
共 50 条
  • [1] Prospective studies of cothymia (mixed anxiety-depression): how do they inform clinical practice?
    Peter Tyrer
    Helen Seivewright
    Shaeda Simmonds
    Tony Johnson
    European Archives of Psychiatry and Clinical Neuroscience, 2001, 251 : 53 - 56
  • [2] Identification and validation of mixed anxiety-depression
    Hettema, J. M.
    Aggen, S. H.
    Kubarych, T. S.
    Neale, M. C.
    Kendler, K. S.
    PSYCHOLOGICAL MEDICINE, 2015, 45 (14) : 3075 - 3084
  • [3] SUBSYNDROMAL (MIXED) ANXIETY-DEPRESSION IN PRIMARY-CARE
    ROYBYRNE, P
    KATON, W
    BROADHEAD, WE
    LEPINE, JP
    RICHARDS, J
    BRANTLEY, PJ
    RUSSO, J
    ZINBARG, R
    BARLOW, D
    LIEBOWITZ, M
    JOURNAL OF GENERAL INTERNAL MEDICINE, 1994, 9 (09) : 507 - 512
  • [4] Unravelling the Prospective Associations Between Mixed Anxiety-Depression and Insomnia During the Course of Cognitive Behavioral Therapy
    Thun, Eirunn
    Sivertsen, Borge
    Knapstad, Marit
    Smith, Otto R. F.
    PSYCHOSOMATIC MEDICINE, 2019, 81 (04): : 333 - 340
  • [5] An open-label pilot study of fluvoxamine for mixed anxiety-depression
    Houck, C
    PSYCHOPHARMACOLOGY BULLETIN, 1998, 34 (02) : 225 - 227
  • [6] The relevance of 'mixed anxiety and depression' as a diagnostic category in clinical practice
    Moeller, Hans-Juergen
    Bandelow, Borwin
    Volz, Hans-Peter
    Barnikol, Utako Birgit
    Seifritz, Erich
    Kasper, Siegfried
    EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE, 2016, 266 (08) : 725 - 736
  • [7] Comorbidity and risk-pattems of depression, generalised anxiety disorder and mixed anxiety-depression in later life: results from the AMSTEL study
    Schoevers, RA
    Beekman, ATF
    Deeg, DJH
    Jonker, C
    van Tilburg, W
    INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY, 2003, 18 (11) : 994 - 1001
  • [8] Efficacy of Silexan in mixed anxiety-depression - A randomized, placebo-controlled trial
    Kasper, Siegfried
    Volz, Hans-Peter
    Dienel, Angelika
    Schlaefke, Sandra
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2016, 26 (02) : 331 - 340
  • [9] The interaction of reinforcement sensitivity and life events in the prediction of anhedonic depression and mixed anxiety-depression symptoms
    Hundt, Natalie E.
    Nelson-Gray, Rosemery O.
    Kimbrel, Nathan A.
    Mitchell, John T.
    Kwapil, Thomas R.
    PERSONALITY AND INDIVIDUAL DIFFERENCES, 2007, 43 (05) : 1001 - 1012
  • [10] Prevalence, Symptom Profiles, and Correlates of Mixed Anxiety-Depression in Male and Female Autistic Youth
    Bitsika, Vicki
    Sharpley, Christopher F.
    Vessey, Kirstan A.
    Evans, Ian D.
    NEUROSCI, 2024, 5 (03): : 315 - 327